Sr One Capital Management, LP

Sr One Capital Management, LP reported 17 holdings worth US$1.15B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Sr One Capital Management, LP reported 17 holdings worth US$1.15B as of Sep 30, 2026. Largest: Veradermics, Incorporated, ADARx Pharmaceuticals, Inc. and Zenas BioPharma, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
17
Value as reported
US$1.15B

The filing in full

CompanySharesValue as reported% of portfolio
Veradermics, Incorporated2.08MUS$252M21.9%
ADARx Pharmaceuticals, Inc.9.94MUS$198M17.2%
Zenas BioPharma, Inc.5.04MUS$136M11.8%
Avalyn Pharma Inc.3.31MUS$94.3M8.2%
Odyssey Therapeutics, Inc.3.79MUS$84.3M7.3%
Design Therapeutics, Inc.6.53MUS$82M7.1%
ORIC Pharmaceuticals, Inc.4.62MUS$62.2M5.4%
Mineralys Therapeutics, Inc.1.56MUS$39.3M3.4%
Mobia Medical, Inc.1.99MUS$18.8M1.6%
ARS Pharmaceuticals, Inc.4.01MUS$17.3M1.5%
Alumis Inc.1.96MUS$14.5M1.3%
Nkarta, Inc.3.33MUS$8.73M0.76%
Ultragenyx Pharmaceutical Inc.138KUS$2.07M0.18%
enGene Holdings Inc.0US$00.00%

Source

Download original · View original at SEC

Related